Ion Exchange Reports Mixed Q1 Results Amid SAP Transition Challenges
Ion Exchange (India) Limited reported a 3% increase in Q1 consolidated operating income to Rs 583.20 crores, with net profit growing 8% to Rs 48.40 crores. The engineering division saw a 2% revenue decline but 48% EBIT growth. The chemical segment faced challenges with a 5% revenue drop. The consumer products division showed strong 36% growth. The company faced SAP implementation issues, but operations have largely stabilized. A new resin production plant at Roha is set to commission this quarter, primarily for export markets. The UP Jal Nigam project execution remains slow due to funding issues.

*this image is generated using AI for illustrative purposes only.
Ion Exchange (India) Limited , a leading player in the water treatment solutions industry, reported a mixed performance for the first quarter, as the company navigated through challenges related to its SAP implementation while making progress on various fronts.
Financial Highlights
The company reported consolidated operating income of Rs 583.20 crores for Q1, representing a modest 3% year-on-year increase. However, EBITDA declined by 2% to Rs 62.70 crores, with margins settling at 10.75%. Despite these headwinds, net profit grew by 8% to Rs 48.40 crores, with the PAT margin standing at 8.30%.
Segment Performance
Engineering Division
The engineering division experienced a 2% year-on-year reduction in revenue, reaching Rs 318.00 crores. However, EBIT for this segment surged by 48% to Rs 27.80 crores, benefiting from a one-time cost rebate on a large EPC contract. The company's order book remained robust at Rs 2,664.00 crores, with a promising bid pipeline exceeding Rs 9,200.00 crores.
Chemical Division
The chemical segment faced challenges, with revenue dropping by 5% to Rs 188.90 crores and EBIT declining by 6% to Rs 46.70 crores. Despite these setbacks, the division maintained its margin profile.
Consumer Products Division
The consumer products division emerged as a bright spot, showcasing strong growth of 36% to reach Rs 90.20 crores. Losses in this segment narrowed significantly from Rs 3.40 crores to Rs 0.90 crores, indicating improved operational efficiency.
Operational Updates
SAP Implementation Challenges
The company's migration to the SAP environment led to transition-related challenges that impacted business volumes, particularly affecting the chemicals division in April. However, management reported that operations have largely stabilized since then.
Roha Manufacturing Plant
Ion Exchange is on track to commission its new greenfield manufacturing plant at Roha for resin production in the current quarter. This facility is primarily designed to cater to export markets across the Americas, Europe, Asia-Pacific, and the Middle East.
Project Execution
The execution of the UP Jal Nigam project remains slow due to fund availability issues. On a positive note, the company received payments from Sri Lankan authorities against approved bills, which is expected to facilitate the expeditious closure of that contract.
Future Outlook
While the company faces near-term challenges, particularly in its engineering and chemical divisions, management remains optimistic about long-term prospects. The consumer products division's strong performance and the upcoming commissioning of the Roha plant are expected to drive growth in the coming quarters.
Ion Exchange continues to focus on expanding its presence in both domestic and international markets, with a particular emphasis on high-growth sectors such as semiconductors, solar, and data centers. The company's selective approach to new orders in the engineering segment aims to ensure profitability and sustainable growth.
As Ion Exchange navigates through the current transitional phase, investors will be keenly watching the ramp-up of the Roha facility and the resolution of challenges in the UP Jal Nigam project for signs of improved performance in the coming quarters.
Historical Stock Returns for Ion Exchange
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
-0.39% | +1.01% | -1.47% | -10.53% | -34.85% | +125.50% |